ESSA Pharma Inc

NASDAQ EPIX

Data sourced from iex and EODHD
Download Data

ESSA Pharma Inc Common Stock (Net) 1 year YoY Change (%) for the quarter ending June 30, 2021: 261.30%

ESSA Pharma Inc Common Stock (Net) 1 year YoY Change (%) is 261.30% for the quarter ending June 30, 2021, a 221.44% change year over year. Common Stock (Net) is the net value of the company's common stock after deducting any repurchased shares or treasury stock. The measure "Change (%)" refers to the percentage change in the value of a financial metric between two time points. This measure provides a relative perspective on the magnitude of change.
  • ESSA Pharma Inc Common Stock (Net) for the quarter ending March 31, 2021 was USD 276.74 M, a 261.14% change year over year.
  • ESSA Pharma Inc Common Stock (Net) for the quarter ending March 31, 2020 was USD 76.63 M, a 80.96% change year over year.
NASDAQ: EPIX

ESSA Pharma Inc

CEO Dr. David Ross Parkinson M.D.
IPO Date July 9, 2015
Location Canada
Headquarters 999 West Broadway, Vancouver, BC, Canada, V5Z 1K5
Employees 50
Sector Healthcare
Industry Biotechnology
Description

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

StockViz Staff

September 19, 2024

Any question? Send us an email